Evidence map›Paper›PMID 42271075›Full record

ReviewAnnals of biomedical engineering2026

Mechanical Signaling From ECMs to Nuclear Envelopes in Cell Transitions and Fate Decisions: A Review and Perspective on Adhesion-Niche-Based Anti-EndMT and Anti-EMT.

Jichul Kim, Hayeong Jang, Ye Eun Song, Soo-Hong Lee

Abstract readReview
PubMed Publisher
In one paragraph

Review in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jichul KimDepartment of Biomedical Engineering, Dongguk University, Seoul, 04620, Republic of Korea. jichul0kim@gmail.com.ORCID http://orcid.org/0000-0001-9714-3048
Hayeong JangDepartment of Biomedical Engineering, Dongguk University, Seoul, 04620, Republic of Korea.
Ye Eun SongDepartment of Biomedical Engineering, Dongguk University, Seoul, 04620, Republic of Korea.
Soo-Hong LeeDepartment of Biomedical Engineering, Dongguk University, Seoul, 04620, Republic of Korea. soohong@dgu.ac.kr.

Funding

National Research Foundation of Korea 2022R1A2C3004850National Research Foundation of Korea RS-2024-00405381
6 · The paper itself

Abstract

Cells respond to extracellular matrices (ECMs) and generate internal signals associated with genomic and epigenomic changes. Currently, many studies employ direct intracellular chemical, genomic, or epigenomic modulation, which may not always be the optimal avenue for directing cell transitions and fate decisions in therapeutic contexts. This paper aims to conceptualize adhesion-niche-based mechanobiological strategies that are free from direct intracellular modulation, but effective in controlling cell transitions and fate decisions, such as endothelial-to-mesenchymal transition (EndMT), epithelial-to-mesenchymal transition (EMT), as well as reprogramming and differentiation processes associated with them. To this end, we review the molecular and biophysical mechanisms of cellular interactions with two-dimensional ECMs. Across ECMs, focal adhesions, the cytoplasm, and the nuclear envelope, we discuss how mechanical signals propagate and generate biological events. By providing an integrated picture of the mechanobiological responses of contractile cells on two-dimensional ECMs, our review offers novel perspectives on anti-EndMT and anti-EMT, based on adhesion-niche-dependent modulation of biphasic mechanotransduction.

Indexed as

AdhesionBiphasic mechanotransductionCell fate decisionEndothelial-to-mesenchymal transitionEpithelial-to-mesenchymal transitionsExtracellular matrix rigidity

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.